As for further screening factors involved in clinical decision-making, hemoglobin, eGFR, BNP at admission and the proportion of cancer diagnosis within 1-year or metastatic cancer may, partially, explain these results. The gene discussed is NPPB; the disease is metastatic malignant neoplasm.